Home › Funds › Legato Capital Management LLC › TVTX

Legato Capital Management LLC position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Legato Capital Management LLC reported holding 87,833 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 0.44% of its reported portfolio and ranking #37 among its reported holdings. Legato Capital Management LLC has disclosed TVTX holdings in 5 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)87.83K sh
Reported value held$4.99M
Portfolio Weight0.44%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Legato Capital Management LLC's TVTX position evolved

Legato Capital Management LLC first disclosed a stake in TVTX in Q1 2025 at 32,731 shares (US$587K). The position peaked in Q2 2026 at 87,833 shares, worth US$5.0M. Across 5 filings, Legato Capital Management LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 87,833 shares valued at US$5.0M — an increase of 23,723 shares quarter over quarter.. Notable position changes include a 27% trim in Q1 2026 (shares rose 91% over the following quarter), a 37% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 32.73K $586.54K New
Q3 2025 71.03K $1.70M New
Q4 2025 87.54K $3.34M Add
Q1 2026 64.11K $1.90M Reduce
Q2 2026 87.83K $4.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Legato Capital Management LLC held TVTX?

Legato Capital Management LLC has disclosed TVTX holdings in 5 of the last 6 reported quarters, going back to Q1 2025.

What is Legato Capital Management LLC's current position in TVTX?

As of Q2 2026, Legato Capital Management LLC holds 87.83K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $4.99M, representing 0.44% of its reported portfolio and ranking #37.

Has Legato Capital Management LLC been buying or selling TVTX?

In the latest 13F filing (Q2 2026), Legato Capital Management LLC increased its position in TVTX. The position peaked in Q2 2026 at 87.83K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.